Gen Li, PhD, MBA
Prior to founding Phesi in 2007, Dr. Li was head of productivity for Pfizer Worldwide Clinical Development, a position he assumed following Pfizer’s acquisition of Pharmacia, where Dr. Li delivered the first implementation of productivity measurement for clinical development. While at Pharmacia and Pfizer, he contributed to the Centre for Medicines Research (CMR) International database for pharmaceutical R&D performance. He was also instrumental in creating the KMR productivity mode. Previously, Dr. Li led the creation of the first computer-automated resource management system at Bristol-Myers Squibb. Dr. Li received the prestigious Upjohn Award from Pfizer/Pharmacia. He earned his Ph.D. in Biochemistry from Beijing University and an MBA from the Johnson Graduate School of Management at Cornell University.
Digital Twins and Trial Arms: Is the Future of Single-Arm Oncology Trials Already Here?
Building a Stronger Clinical Trials Industry Post-Pandemic: Modal-Guided Design
Closer Relationships Between Sponsors and Regulators Could Transform Clinical Trials
